Strategic Plan
The last Strategic Plan (2019-2022) established as a priority the promotion of an interdisciplinary translational science program in the field of health biotechnology with the commitment to transform the knowledge generated into health products and services. The main objective was to become a unique research center that encompasses scientific excellence, transformative knowledge and translation to bring precision to therapies. As a result of this plan, our scientific metrics improved significantly.
Currently, we have a new Strategic Plan (2023-2026) with which we have attended the María de Maeztu call for Scientific Units of Excellence and whose objective is to become an international reference center in molecular and preclinical biotechnology research.